Global mHealth Apps Market Growth (Status and Outlook) 2022-2028
SKU ID : LPI-19901110 | Publishing Date : 11-Jan-2022 | No. of pages : 104
The United States mHealth Apps market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global mHealth Apps market, reaching US$ million by the year 2028. As for the Europe mHealth Apps landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main mHealth Apps players cover Abbott Laboratories, Johnson and Johnson, AstraZeneca PLC, and F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of mHealth Apps market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Nutrition & Diet
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Middle East & Africa
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Johnson and Johnson
F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Merck and Co., Inc.
Frequently Asked Questions
- By product type
- By End User/Applications
- By Technology
- By Region